BRENTWOOD, Tenn., April 03, 2025--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining UPMC, Mr. DeMichiei held various executive roles with the General Electric Company and PricewaterhouseCoopers. He is a graduate of the University of Pittsburgh. "We are pleased to welcome Rob to our board of directors," said Marty Bonick, Ardent Health president and CEO. "His deep understanding of healthcare finance and operations and extensive board experience will be instrumental in guiding Ardent’s continued growth and focus on operational excellence." Mr. DeMichiei also serves on the boards of several organizations, including Waystar Holding Corp. (Nasdaq: WAY), Ampco-Pittsburgh Corporation (NYSE: AP), and Auto Club Enterprises/AAA, and is a strategic advisor to Health Catalyst (Nasdaq: HCAT) and Omega Healthcare Management Services. He will serve on the board’s Audit & Compliance Committee and the Nominating & Corporate Governance Committee. "Rob’s governance experience with publicly traded companies brings valuable insight and perspective," said Mark Sotir, chairman of the Ardent Health board. "His background – along with his leadership of one of the nation’s preeminent academic health systems – will be a tremendous asset as we continue strengthening our board and advancing Ardent’s long-term strategy." About Ardent Health Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and 280 sites of care with over 1,800 affiliated providers across six states. For more information, please visit ardenthealth.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20250403944600/en/ Story Continues Contacts Investor Contact: Dave Styblo [email protected] (615) 296-3016 Media Contact: Rebecca Kirkham [email protected] (615) 296-3635 View Comments
Ardent Health Appoints Robert DeMichiei to Board of Directors
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...